Novavax—a biotechnology company located in Gaithersburg—has been awarded $1.6 billion to accelerate the development of a potential COVID-19 vaccine. The company announced Tuesday that it has been selected to participate in … Continue reading Novavax of Gaithersburg Awarded $1.6 Billion in Federal Funding to Develop Potential COVID-19 Vaccine